# Sources — Mary McLeod Bethune

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

Accessed November 5, 2026. The canonical source metadata and claim links are in `case.json`.

## Historical evidence

1. National Park Service. “Mary McLeod Bethune” (from the report *The Roosevelts and African American Civil Rights Leaders*), last updated January 14, 2024. Supports her birth in Mayesville, South Carolina, on July 10, 1875, as “the fifteenth of seventeen children born to parents, who, along with eight of her older siblings, had been enslaved”; the family’s five acres; that she was the only McLeod child to get an education; her marriage to Albertus Bethune in 1898 and their separation after nine years without divorce; the school she founded in Daytona Beach in 1904; McLeod Hospital (1911) and its role in the influenza pandemic of 1918; the Ku Klux Klan confronting her at the school; the merger with Cookman Institute in 1923; her presidency of the National Association of Colored Women; the Spingarn Medal (1935); her quotation “When they see me, they know that the Negro is present”; the founding of the National Council of Negro Women; and her death “of a heart attack at home on May 20, 1955,” with her essay “My Last Will and Testament” published by *Ebony* afterwards. https://www.nps.gov/hofr/learn/historyculture/mary-mcleod-bethune.htm
2. National Park Service, Mary McLeod Bethune Council House National Historic Site. “The Council House.” Supports her home, “the Retreat,” on the campus in Daytona Beach; her years in apartments in Washington from 1935; and the purchase of 1318 Vermont Avenue by her and the National Council of Negro Women for $15,500 on December 18, 1943. https://home.nps.gov/mamc/learn/historyculture/the-council-house.htm
3. National Park Service. “Mary McLeod Bethune Council House National Historic Site.” Supports the founding of the National Council of Negro Women on December 5, 1935, in New York, and the house as her residence from 1943 to 1955 and the council’s first national headquarters. https://www.nps.gov/articles/mary-mcleod-bethune-council-house.htm
4. Podesta J. “Bethune, Mary McLeod 1875–1955.” *Contemporary Black Biography* (Gale), via Encyclopedia.com. Supports her birth name Mary Jane McLeod, her parents Samuel and Patsy McLeod, her schooling, the separation from her husband and his death in 1918, her presidency of the school from 1904 to 1942 and as president emeritus from 1942 to 1955, the renaming as Bethune-Cookman College in 1929, her direction of the Division of Negro Affairs of the National Youth Administration from 1935 to 1943, the Black Cabinet, and her death on May 18, 1955, in Daytona Beach. https://www.encyclopedia.com/people/social-sciences-and-law/education-biographies/mary-mcleod-bethune
5. Baxter D. “Bethune, Mary McLeod (1875–1955).” *Women in World History: A Biographical Encyclopedia* (Gale), via Encyclopedia.com (same page). Supports: “For many years, she had suffered from chronic asthma which increasingly restricted her ability to travel. Following a particularly severe attack in 1942, Bethune formally relinquished the presidency of her beloved Bethune-Cookman College”; her retirement from public life on her 75th birthday in 1950; the 1952 journey to Liberia; and her death of a heart attack on May 18, 1955. https://www.encyclopedia.com/people/social-sciences-and-law/education-biographies/mary-mcleod-bethune
6. University Publications of America (LexisNexis). *Mary McLeod Bethune Papers: The Bethune Foundation Collection*, Part 1, guide to the microfilm edition. Lists “Bethune asthma attacks” as a major topic of her administrative correspondence for January to March and April to June 1943; describes her health problems as “a recurrent subject”; lists “Bethune description of Gay Asthmatic Clinic in Biloxi, Mississippi” (1950) and “Bethune failing health and hospitalization” (1952); and states that she “retired to Florida in the late 1940s while she was still an active president of the NCNW.” https://www.lexisnexis.com/documents/academic/upa_cis/1388_marmclbethfoundpt1.pdf
7. HISTMED Master Roster v3. Internal project source. Its entries were provisional and were not treated as independent corroboration.

## Clinical guidance

1. Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention, 2025 update. Confirmation of variable airflow limitation before treatment where possible; track 1 with ICS-formoterol as reliever and maintenance; no SABA-only treatment; technique and adherence checks before stepping up; written action plans; management and review after exacerbations; the definition of severe asthma and the assessment for biologic therapy; and treatment of comorbidities such as chronic rhinosinusitis, reflux and obesity. https://ginasthma.org/reports/
2. Expert Panel Working Group of the NHLBI National Asthma Education and Prevention Program Coordinating Committee. “2020 Focused Updates to the Asthma Management Guidelines.” *J Allergy Clin Immunol* 2020;146(6):1217–1270 (PMID 33280709). FeNO as an adjunct when the diagnosis is uncertain and to monitor anti-inflammatory therapy; single maintenance and reliever therapy with ICS-formoterol at steps 3 and 4; allergen mitigation when sensitization is shown. https://pubmed.ncbi.nlm.nih.gov/33280709/
3. CMID: Clinical Monitoring Intelligence Database, asthma and hypertension monographs (Aether Forge, 2026): Asthma Control Test, technique, adherence, reliever use, exacerbation history, triggers, action plan and step assessment at every visit; spirometry at diagnosis and after stabilization; review within a week of any exacerbation; FeNO and blood eosinophils for phenotyping; comorbidity and vaccination review; biologic assessment only for severe or uncontrolled asthma; and, for hypertension, blood pressure at every visit with home readings, yearly kidney function, potassium, lipids, glucose or A1c and urine albumin, TSH at diagnosis, a baseline ECG, echocardiography for LVH and yearly fundoscopy. https://patrickrutledge.github.io/topthirty/
4. Heidenreich PA, et al. “2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: Executive Summary.” *J Am Coll Cardiol* 2022;79(17):1757–1780 (PMID 35379504). Natriuretic peptides and echocardiography in the evaluation of breathlessness. https://pubmed.ncbi.nlm.nih.gov/35379504/
5. 2025 AHA/ACC multisociety Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults. *J Am Coll Cardiol* 2025 (PMID 40815242). Home blood pressure monitoring, a target below 130/80, and first-line drug classes. https://pubmed.ncbi.nlm.nih.gov/40815242/
6. Bhakta NR, et al. “Race and Ethnicity in Pulmonary Function Test Interpretation: An Official American Thoracic Society Statement.” *Am J Respir Crit Care Med* 2023;207(8):978–995 (PMID 36973004). Replacement of race-specific reference equations with race-neutral (GLI Global) equations. https://pubmed.ncbi.nlm.nih.gov/36973004/
7. Pate CA, et al. “Asthma Surveillance — United States, 2006–2018.” *MMWR Surveill Summ* 2021;70(5):1–32 (PMID 34529643). Current asthma prevalence and emergency or urgent care visits were higher among non-Hispanic Black persons, and asthma deaths were higher among adults, females and Black persons. https://pubmed.ncbi.nlm.nih.gov/34529643/
8. Preventive care: Centers for Medicare & Medicaid Services, Medicare Wellness Visits; the Medicare Preventive Services reference (Aether Forge, 2026); U.S. Preventive Services Task Force recommendations on breast cancer (2024), colorectal cancer (2021), osteoporosis (2025) and falls prevention (2024); Centers for Disease Control and Prevention, Adult Immunization Schedule by Age. https://www.cms.gov/outreach-and-education/medicare-learning-network-mln/mlnproducts/preventive-services/medicare-wellness-visits.html, https://patrickrutledge.github.io/preventative_services/, https://www.cdc.gov/vaccines/hcp/imz-schedules/adult-age.html

## Editorial resolutions

- **Recent-death rule.** She died in 1955, so the rule does not apply. The claims are still limited to what the fetched sources state.
- **Sources not read.** The *New York Times* obituary, the Library of Congress, the Florida Memory archive, Bethune-Cookman University and the National Council of Negro Women pages were not fetched successfully or not reached, and no peer-reviewed account of her health was found; none is cited.
- **Asthma (D, one reference work).** Her chronic asthma, its restriction of her travel and the severe attack of 1942 come from *Women in World History* (CLM-0005); the University Publications of America guide to her foundation’s papers independently lists “Bethune asthma attacks” in her 1943 correspondence (CLM-0006). Both are graded D with certainty “probable” because neither gives clinical detail. The age at onset, the treatment she received and any testing are not recorded and are not claimed.
- **Sinus surgery not used.** The assignment mentioned sinus surgery at Johns Hopkins in the 1930s. No fetched source mentions it (searches found only unrelated material about the Canadian surgeon Norman Bethune), so it is left out of the claims and of the modern episode. The modern chronic rhinosinusitis is synthetic; the record gives her no past sinus operation so that nothing reads as a claim about the unverified surgery.
- **Heart disease (R).** The sources say only that she died of a heart attack. No heart symptoms, blood pressure readings or cardiac diagnosis during her life were found. CLM-0011 records, as R with certainty “possible,” that a fatal heart attack at 79 is most consistent with coronary heart disease. The modern hypertensive heart disease without heart failure (I11.9) is synthetic, chosen so that the teaching can exclude heart failure as the cause of her breathlessness while still finding and treating heart disease; it is not linked to the death claim.
- **Date of death.** Two reference biographies give May 18, 1955, in Daytona Beach; one National Park Service page gives May 20 and says she died at home. May 18 is preferred; May 20 is recorded as a conflicting alternative.
- **Merger date.** The National Park Service dates the merger with Cookman Institute to 1923; *Contemporary Black Biography* says the school was renamed Bethune-Cookman College in 1929. Both are recorded in CLM-0003.
- **Index age and dates.** The synthetic date of birth is July 10, 1953 (shift 78 years). The index visit on March 9, 2026 maps to March 9, 1948, when she was 72: six years after the documented severe attack of 1942 and before she left public life in 1950. All visits map to March to September 1948, within her lifetime. Index age 72 is within the requested range of 70 to 74; she turns 73 before the fourth visit. The visits are not a claim about her real care or whereabouts in 1948; the modern episode places her home in Daytona Beach with monthly travel to Washington, as her documented life did.
- **Intake claims.** Claims about events after March 1948 (her retirement in 1950, the 1950 and 1952 entries in her papers, her death) are linked only to later timeline events and do not appear in the intake documents.
- **Presenting problems.** Wheeze, cough and breathlessness (R06.2) are resolved at the diagnosis visit on March 23, 2026, when asthma (J45.40, both_with_link to the documented asthma), hypertensive heart disease without heart failure (I11.9) and hyperlipidemia (E78.5) are recorded. Nasal congestion (R09.81) is resolved on May 4, 2026, when chronic rhinosinusitis without nasal polyps (J32.9) is recorded after nasal endoscopy. Reflux (K21.9) and obesity, class 1 (E66.811) are recorded at intake. The intake documents state only what was known then.
- **Diagnostic choices.** Asthma is separated from COPD by a 270 mL (21 percent) bronchodilator response, a post-bronchodilator FEV1/FVC of 0.72 and a normal DLCO in a never smoker; heart failure is excluded by a BNP of 48 pg/mL, a normal ejection fraction, a normal left atrium and no edema. The ICD-10-CM code J45.40 (moderate persistent) is used for billing; GINA does not grade severity before treatment, and her severity is judged by the treatment that controls her (low to medium dose ICS-formoterol), so she does not have severe asthma.
- **Treatment choices.** GINA track 1 budesonide-formoterol maintenance and reliever from the diagnosis, replacing albuterol alone; at six weeks the inhaler technique and adherence were corrected rather than the dose stepped up; during the exacerbation the maintenance dose was increased to two inhalations twice daily with five days of prednisone, and stepped back down once control was regained. Amlodipine was chosen for hypertension because beta-blockers can worsen asthma and an ACE inhibitor's cough would confuse the asthma review. A moderate-intensity statin was started for an estimated 10-year ASCVD risk above 20 percent. Biologic therapy was assessed and found not indicated. These are clinical judgment calls for review.
- **Obesity.** Recorded in her words and with her agreement; the record states plainly that her breathlessness is from asthma and not her weight, offers a dietitian and a walking plan as she chooses, and leaves a discussion of weight medicines to her.
- **Equity.** The record reads her spirometry with race-neutral GLI Global equations (ATS 2023) and says why that matters, and cites the documented higher asthma death rates among Black Americans (MMWR 2021). The history of clinicians dismissing her breathlessness as weight or age is synthetic and not a claim about her real care.
- **Synthetic clinical picture.** All visits, results, imaging, lung function, FeNO, IgE and allergen results, the echocardiogram, her height (163 cm) and weights, and every medicine are synthetic. Qualitative results (specific IgE, nasal endoscopy, ECG, chest X-ray) are in procedure and note text.
- **Sick visit.** A moderate asthma exacerbation with a cold (J45.41), chosen because it is the commonest and most instructive event in asthma care: it tests the action plan, the distinction from heart failure and the short oral corticosteroid course, and insinuates no undocumented real diagnosis. It is not a claim about any documented attack.
- **Annual wellness visit.** A subsequent annual wellness visit at 73 (HCPCS G0439 and CPT 99497 in plain text): influenza, COVID-19 and RSV vaccines; PCV20 already given in March; zoster and Tdap up to date from synthetic history; DXA ordered (65 or older with a recent prednisone course); mammography ordered; and advance care planning with an unnamed surrogate.
- **Focused visits.** The three chronic-care follow-ups (diagnosis and consultation, six weeks, and six weeks after the exacerbation) are documented as focused visits on GINA 2025, the 2020 NAEPP focused update, the CMID asthma and hypertension monographs, the 2025 AHA/ACC blood pressure guideline and the ATS race-neutral statement. Synthetic findings introduced: chronic rhinosinusitis without nasal polyps on nasal endoscopy. One protocol deviation is recorded instead of an invented result: the in-person review within a week of the exacerbation that the CMID schedule and GINA call for was not booked (the nurse telephoned on days 2 and 7); no harm, since she recovered fully and was well controlled six weeks later; corrective action: the action plan and the exacerbation order set now book a visit within seven days.
- **Consultation.** The pulmonology referral and the consultation by Samuel Oyelowo-Brandt, MD (a fictional consultant), on the diagnosis day, are **S**. The consultant answers the six referral questions in line with what the record shows afterwards: asthma, not COPD, with heart failure excluded and hypertensive heart disease found; race-neutral interpretation; budesonide-formoterol maintenance and reliever with albuterol stopped; type 2 phenotype without current eligibility for biologics; upper airway, reflux and blood pressure treatment; and an action plan, technique checks and vaccinations.
- **Real people.** Her husband appears only in the claims; her son and grandchildren are not named. No relative, colleague or friend is given a decision, a statement or a health fact in the modern episode, and the health care surrogate is unnamed. The president and the first lady of her Washington years are not named in the record, and no other figure with a record in the dataset is named.
